WhiteOak Capital Pharma and Healthcare Fund Regular - Growth
WhiteOak Capital Pharma and Healthcare Fund Regular - Growth: Mutual Fund Overview
WhiteOak Capital Pharma and Healthcare Fund Regular - Growth is an Sectoral-Pharma mutual fund with over 2.09 years of performance history. The scheme manages an AUM of ₹533.04 Cr and has a NAV of ₹13.897. It is rated 'Not Rated' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 15.03%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 15.03% at 12 Mar 2026 08:52 PM
Fund Details
NAV 13.897
Sub-Type Sectoral-Pharma
Rating Not Rated
Min. SIP Amount ₹100.0
Fund Age(Year) 2.09
Fund Size(in Crores) 533.04
Fund Performance
1 Month 1.0%
3 Month -0.07%
6 Month -1.25%
1 Year 15.03%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.7%) Market Cap Small Cap 46.53 Mid Cap 24.92 Large Cap 27.24 Top Sectors Healthcare 93.24 Chemicals 3.06 Materials 1.78 Services 0.61 Top Holding Max Healthcare Institute 6.34 Abbott India 0.58 Narayana Hrudayalaya 1.94 JB Chemicals 9.44 Krishna Institute 3.95 Shilpa Medicare 0.52 Aether Industries 1.26 Pfizer 1.73 Shaily Eng Plastics 1.78 Sudeep Pharma 0.75 Navin Fluorine International 1.6 Laurus Labs 4.33 Thyrocare Technologies 0.99 Divi's Laboratories 5.62 Aarti Pharmalabs 0.61 Strides Pharma Science 1.18 CORONA Remedies 2.31 Dr. Reddy's Laboratories 0.96 Neuland Laboratories 1.46 Apollo Hospitals Enterprise 5.43 Astrazeneca Pharma India 1.48 Alkem Laboratories 0.54 Dr. Lal Pathlabs 1.17 Aurobindo Pharma 3.3 Sun Pharmaceutical Industries 11.95 Orchid Pharma 0.26 Emcure Pharmaceuticals 1.7 Torrent Pharmaceuticals 0.29 Sai Life Sciences 2.46 Kovai Medical Center & Hospital 1.32 Supriya Lifescience 0.84 Lupin 5.29 Tatva Chintan Pharma Chem 0.2 Dr Agarwals Eye Hospital 0.33 Ajanta Pharma 2.35 Vijaya Diagnostic Centre 1.14 Poly Medicure 0.29 Zydus Lifesciences 0.49 Fortis Healthcare 5.62 Zota Health Care 0.66 Ipca Laboratories 1.96 Acutaas Chemicals 2.25
Debt & Others (1.2999999999999998%) Sector Allocation Treasury Bills 2.4 Net Payables -4.09 CBLO 2.99 Debt Credit Ratings Debt Category Others -1.1 Reserve Bank of India 2.4
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Manufacturing Equity Fund Regular-Growth Ret 1M -3.42% Ret 1Y 16.99% Ret 3Y 20.7% Ret 5Y 14.2%
Equity, Flexi Cap funds Aditya Birla Sun Life Manufacturing Equity Fund Regular-IDCW Ret 1M -3.42% Ret 1Y 16.99% Ret 3Y 20.7% Ret 5Y 14.2%
Equity, Flexi Cap funds Aditya Birla Sun Life Manufacturing Equity Fund Regular-IDCW Reinvestment Ret 1M -3.42% Ret 1Y 16.99% Ret 3Y 20.7% Ret 5Y 14.2%
Equity, Flexi Cap funds Axis India Manufacturing Fund Regular-Growth Ret 1M -3.46% Ret 1Y 16.44% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Axis India Manufacturing Fund Regular-IDCW Payout Ret 1M -3.46% Ret 1Y 16.44% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Axis India Manufacturing Fund Regular-IDCW Reinvestment Ret 1M -3.46% Ret 1Y 16.44% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Manufacturing Fund Regular - Growth Ret 1M -2.52% Ret 1Y 20.65% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Manufacturing Fund Regular - IDCW Payout Ret 1M -2.52% Ret 1Y 20.65% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Manufacturing Fund Regular - IDCW Reinvestment Ret 1M -2.52% Ret 1Y 20.65% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Canara Robeco Manufacturing Fund Regular - Growth Ret 1M -4.76% Ret 1Y 15.16% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Canara Robeco Manufacturing Fund Regular - IDCW Payout Ret 1M -4.76% Ret 1Y 15.16% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.36%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Trupti Agrawal
Education Ms. Agrawal has done B.Com and CA.
Experience Prior to joining WhiteOak Capital Mutual Fund, she has worked with L&T Infrastructure Finance Co. Ltd. and Ernst & Young.
Ashish Agrawal
Education PGDBM in Finance from Institute of Management Technology, Ghaziabad and Bachelor of Commerce from University of Lucknow
Experience Prior to joining Whiteoak Capital AMC, he was working with Motilal Owal Asset Management Co. Ltd from 2016 till date. Citigroup Global Markets Ltd from 2010 to 2016
Ramesh Mantri
Education Mr. Mantri is an MBA, CFA and CA
Experience Prior to joining WhiteOak Capital Mutual Fund, he has worked with WhiteOak Capital Management, Ashoka Capital Advisers, Smith Management, and CRISIL.
Piyush Baranwal
Education Mr.Piyush Baranwal is a B. Tech. in Electronics and communication from Manipal Institute of Technology,Manipal.He completed PGDBM in Finance from S.P.Jain Institute of Management and Reserch and CFA.
Experience Prior to joining WhiteOak Capital Mutual Fund he has worked with BOI AXA, Morgan Stanley Investment Management (Jan, 2011-June, 2014) and Principal Pnb AMC as a Dealer- Fixed Income (May, 2008-Jan, 2011).
Dheeresh Pathak
Education Mr. Pathak has done B.E in Electronics Engineering and a PGDBM from MDI Gurgaon
Experience Prior to joining WhiteOak Capital Mutual Fund, he has worked with Goldman Sachs
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 13
Date of Incorporation 2024-02-06
Total AUM 33884.44
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.